To Announce the ex-dividend record date and
cash dividend distribution date approved by the Board
of Directors
Date of events
2022/05/30
To which item it meets
paragraph 14
Statement
1.Date of the resolution by the board of directors or shareholders meeting
or decision by the Company:2022/05/30
2.Type of ex-rights or ex-dividend (please enter: "Ex-rights",
"Ex-dividend", or "Ex-rights and dividend"):Ex-dividend
3.Type and monetary amount of dividend distribution:
To distribute cash dividend NT$ 0.48 per share.
4.Ex-rights (ex-dividend) trading date:2022/07/07
5.Last date before book closure:2022/07/08
6.Book closure starting date:2022/07/11
7.Book closure ending date:2022/07/15
8.Ex-rights (ex-dividend) record date:2022/07/15
9.Any other matters that need to be specified:
Cash dividend distribution date:2022/08/02
Attachments
Original Link
Original Document
Permalink
Disclaimer
ScinoPharm Taiwan Ltd. published this content on 30 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 May 2022 16:38:06 UTC.
ScinoPharm Taiwan Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of active pharmaceutical ingredients. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The Company is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The Company operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.